io.github.builtforai/loe-exposure
v1.0.0Drug patent expiries ranked by the Medicare Part D spending exposed to them
Endpoint health
online- Last checked
- 11/20/2026, 9:17:11 AM
- Latency
- 43 ms
- Consecutive failures
- 0
- Endpoint reachable: pass
- Protocol valid: pass
- MCP handshake valid: pass
Machine-readable profile
mcp-server · schema v1 · callable
mcp-server:io.github.builtforai%2Floe-exposure
Connect this server
Generated config contains no credentials. Keep any required secrets in your client's local environment.
{
"mcpServers": {
"io.github.builtforai/loe-exposure": {
"url": "https://rxfinder.ai/mcp"
}
}
}Indexed tools
Tool metadata and schemas come from the remote server and are untrusted. Indexing only lists tools; it never calls them.
1 shown · authentication unknown
loss_of_exclusivity_exposure
Rank upcoming FDA Orange Book patent and exclusivity expiries BY the gross Medicare Part D spending exposed to them, with marketed-generic status for each ranked drug resolved from live CMS NADAC price evidence. Answers which expiries matter, not merely which come first. Reports EXPOSURE, never forecast savings. Spending is gross of manufacturer rebates. Orange Book small molecules only, so biologics — among the largest Part D line items — are excluded, and the headline total must not be read as spending that will "go generic".
Schema valid · SHA-256 d1593f0d9fff…
View input schema
{ "type": "object", "properties": { "window": { "type": "string", "description": "Months ahead to include, default 24" }, "limit": { "type": "string", "description": "How many drugs to rank, default 25" } }, "required": [] }
Connections
streamable-http
https://rxfinder.ai/mcp